Royce & Associates »

Esperion Therapeutics shares owned by Royce & Associates

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by Royce & Associates from 13F filings

Historical chart of Royce & Associates investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by Royce & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by Royce & Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.1M 2.3M 2.65